Search

[Display omitted] • Microfiltration PTFE hollow fibres were transformed into durable, high value OSN membranes. • A PEI/PIP based polyamide thin film was successfully synthesized on PTFE hollow fibre substrates. • A two-time interfacial polymerization was conducted to obtain a defect-free polyamide layer. • The resultant membranes could withstand strong aprotic solvents like DMF and DMSO. • The membranes had high solute rejections, of up to 95 % methyl orange (327 Da) rejection in DMF. Polymeric membranes have been extensively studied for organic solvent nanofiltration (OSN) but many fail to show sufficient chemical resistance in strong solvents like dimethylformamide (DMF) and dimethyl sulfoxide (DMSO). This study focuses on harnessing the outstanding chemical resistance of polytetrafluoroethylene (PTFE), to develop polyamide-PTFE thin film composite (TFC) membranes that are resistant to such aprotic solvents. A defect-free polyamide thin film layer was successfully synthesized on the microfiltration PTFE hollow fibre substrates, overcoming challenges such as large and uneven pore size, and hydrophobicity of the PTFE substrates. A simple polydopamine (PDA) coating was carried out to improve the substrate's hydrophilicity prior to the polyamide synthesis via interfacial polymerization (IP). Polyethyleneimine (PEI) and trimesoyl chloride (TMC) were used as the monomers and a two-time IP method was employed to obtain a defect-free polyamide coating. The synthesized membranes showed high acetonitrile (ACN) and DMF permeabilities of 7.94 and 3.70 lm−2h−1bar−1, respectively, with acid fuchsin (585 Da) rejections of > 90 %. The molecular weight cut-off (MWCO) of the membranes could be further reduced to ∼300 Da by the addition of piperazine (PIP) monomers. The membranes also showed excellent stability and performance in a 72-hour OSN test performed in DMF indicating their great potential in effective molecular separation in harsh solvents. This study demonstrates how a simple modification and coating technique can transform commercially available microfiltration PTFE hollow fibres into durable and high value OSN membranes. [ABSTRACT FROM AUTHOR]

A scaled-up hollow fibre thin-film composite (TFC) module was successfully developed for organic solvent forward osmosis (OSFO) application in the pharmaceutical industry. The membrane consists of cross-linked P84 polyimide substrate with a polyamide selective layer, formed via interfacial polymerisation. The performance of the lab-scale module was compared to the scaled-up module in reverse osmosis and forward osmosis modes. The results from both tests revealed that the solvent permeability of the scaled-up module decreased while its selectivity increased slightly. This might be caused by the uneven distribution of liquids during interfacial polymerisation, leading to varied membrane performance. The scaled-up module was further tested for OSFO performance using a range of PEG-400 concentrations (0.5–2 M) in acetone and isopropanol as draw solutions. At 2 M PEG-400 concentration, the module demonstrated high isopropanol and acetone permeability of 0.63 LMH and 13.9 LMH, respectively. Moreover, the reverse solute flux of PEG-400 in acetone and isopropanol were relatively low at 0.188 g/l and 0.153 g/l, respectively. The module was further tested for OSFO application in the pharmaceutical industry by concentrating levofloxacin in acetone, using 2 M PEG-400 as draw solution. The process was able to concentrate levofloxacin from 1000 ppm to 16,000 ppm with very low reverse solute flux of 0.178 g/l. Therefore, this work presents a scalable TFC membrane for OSFO application in the pharmaceutical industry. [Display omitted] • Scaled-up module (0.4 m2) of TFC hollow fibre membrane for organic solvent forward osmosis process was successfully fabricated. • High porosity (79%) and low structural parameter (217 μm) for membrane substrate was achieved. • Membrane exhibited excellent acetone and IPA solvent flux of 13.9 LMH and 0.63 LMH, respectively, using a 2 M PEG-400 draw solution. • A pharmaceutical stream was concentrated to a factor of 16 with low specific reverse solute flux [ABSTRACT FROM AUTHOR]

A scaled-up hollow fibre thin-film composite (TFC) module was successfully developed for organic solvent forward osmosis (OSFO) application in the pharmaceutical industry. The membrane consists of cross-linked P84 polyimide substrate with a polyamide selective layer, formed via interfacial polymerisation. The performance of the lab-scale module was compared to the scaled-up module in reverse osmosis and forward osmosis modes. The results from both tests revealed that the solvent permeability of the scaled-up module decreased while its selectivity increased slightly. This might be caused by the uneven distribution of liquids during interfacial polymerisation, leading to varied membrane performance. The scaled-up module was further tested for OSFO performance using a range of PEG-400 concentrations (0.5–2 M) in acetone and isopropanol as draw solutions. At 2 M PEG-400 concentration, the module demonstrated high isopropanol and acetone permeability of 0.63 LMH and 13.9 LMH, respectively. Moreover, the reverse solute flux of PEG-400 in acetone and isopropanol were relatively low at 0.188 g/l and 0.153 g/l, respectively. The module was further tested for OSFO application in the pharmaceutical industry by concentrating levofloxacin in acetone, using 2 M PEG-400 as draw solution. The process was able to concentrate levofloxacin from 1000 ppm to 16,000 ppm with very low reverse solute flux of 0.178 g/l. Therefore, this work presents a scalable TFC membrane for OSFO application in the pharmaceutical industry. [Display omitted] • Scaled-up module (0.4 m2) of TFC hollow fibre membrane for organic solvent forward osmosis process was successfully fabricated. • High porosity (79%) and low structural parameter (217 μm) for membrane substrate was achieved. • Membrane exhibited excellent acetone and IPA solvent flux of 13.9 LMH and 0.63 LMH, respectively, using a 2 M PEG-400 draw solution. • A pharmaceutical stream was concentrated to a factor of 16 with low specific reverse solute flux [ABSTRACT FROM AUTHOR]